Clinical Trials and Research

Nyra Medical enrols first patient in mitral valve repair study

The ENHANCE early feasibility study is evaluating the investigational CARLEN System for symptomatic functional mitral regurgitation....

Advita Ortho Unveils New Research Advancing AI-Powered Knee Balancing Technology

Newton converts soft tissue dynamics into actionable intraoperative guidance, supporting more consistent and reproducible surgical execution...

MindMaze Therapeutics Holding SA Technology Powers University of Pittsburgh Stroke Recovery Study

Cervical spinal cord stimulation can immediately improve arm movement after stroke...

Bayer Partners with University of Colorado Anschutz to Accelerate Clinical Trials

Bayer’s first academic medical centre alliance for clinical trial collaboration is designed to accelerate medical discovery and expand patient access to investigational therapies...

AtaCor treats first patient in pivotal extravascular ICD trial

The ALARION-EV study is evaluating a parasternal extravascular ICD system designed to avoid traditional transvenous lead placement....

STARMED gains FDA clearance for benign thyroid nodule ablation

The clearance gives STARMED a thyroid-specific indication for ultrasound-guided percutaneous radiofrequency ablation in eligible adults....

OrthAlign completes first clinical cases with Lantern ASC system

The handheld navigation platform is designed to bring enabling technology to ambulatory surgery centres without the capital burden of robotic systems....

How AI and Metabolomics Are Changing the Way Vets Detect Disease

At the forefront of this innovation is LatusPet, whose proprietary SINO platform analyses hundreds of metabolites simultaneously to identify complex biochemical patterns associated with disease...

Blood Test Screens Dogs for Multiple Diseases at Once, Peer-Reviewed Study Shows

The platform was built and validated specifically for dogs, and LatusPet plans to add further conditions each year, with work underway to extend it to other species...

FDA Grants Breakthrough Device Designation to SkylineDx's Merlin CP-GEP

First and only melanoma gene expression profiling test that is both designated as an FDA Breakthrough Device and included in the NCCN guidelines for T1b and T2a cutaneous melanoma patients...